Yu-Chen Su
Director, Biostatistics & Programming @Stryker
Signup · Get unlimited contacts
WORK HISTORY
Director, Biostatistics & Programming @Stryker
Stryker acquired Inari on Feb 19, 2025 for 4.9B Lead biostatistics, statistical programming, and data management functions
EDUCATION
Washington University in St. Louis
B.S., Biomedical Engineering
University of Southern California
Doctor of Philosophy (PhD), Biostatistics/Statistical Genetics
Washington University School of Medicine in St. Louis
M.S., Biostatistics/Genetic Epidemiology
ABOUT YU-CHEN SU
Clinical significance-focused biostatistics and data science leader with over a decade of success in driving regulatory submission approvals and publications within the pharmaceutical and medical device space. Experienced with neuroscience, GI, cardiovascular, oncology, venous thromboembolism, and chronic limb-threatening ischemia therapeutic areas. Design and lead RCTs, IDEs, PMAs, PMCF/PMS/PMR through regulatory body discussions and clinical evidence generation. Provide statistical innovation in the areas of comparative effectiveness, treatment efficacy gap, and personalized medicine.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.